This website uses cookies to enhance the user experience.
||
A

APPSENS AS918 707 719

Process industry
Limited company
Senterveien 30 4790 LILLESAND, Norge
Industry and manufacturing
/ Process industry
/ 21.200 Manufacture of pharmaceutical preparations

APPSENS AS

Operating
Utvikling og investeringer i produkter og tjenester.
Utvikling av trådløse medisinske sensorer og medisinske APP-løsninger for mobile pasienter.

Keywords

productionpharmaceuticalsantiserablood fractionsvaccineshomeopathic preparationscontraceptive productsbone buildingdiagnostic preparationspregnancy testsbiotechnological medicinescotton woolgasbandagesdressings

Organization

CEO
TY

Tord Ytterdahl1970

Chairman of the board
MA

Morten Andresen1963

Years since formation
9 years
since Mar 17, 2017
Type
Limited company
VAT registered
Yes
Number of employees
8

Ownership

Number of shares and share classes
108,426
1 share class
Total number of shareholders
46
37 companies, 9 persons

Financials

Total operating income 2025
10,802,461
NOK
Annual total result 2025
-10,321,527
NOK
Total equity 2025
7,494,422
NOK
Last update: Jun 3, 2026

Management

Management / administration

NameRoleShares
TY

Tord Ytterdahl

1970

Managing Director/CEO
3.54 %
indirectly

Board

NameRoleShares
MA

Morten Andresen

1963

Chairman-
AT

Anita Tunold

1972

Board Member-
HM

Harald Moræus-Hanssen

1963

Board Member
20.11 %
indirectly
AK

Axel Kogstad Bendvold

1990

Board Member
2.45 %
indirectly
AK

Andreas Karlsen Eskeland

1988

Board Member-
LP

Lars Peder Fosse Fensli

1976

Board Member
4.24 %
indirectly

Others

NameRoleShares
A
AGDER REVISJON AS
Auditor-
L
LILLESAND REGNSKAP OG ØKONOMI AS
Accountant-

Top 10 individual shareholders

NameRoleShares
HM

Harald Moræus-Hanssen

1963

Board Member
20.11 %
indirectly
TR

Thor Reinholt Breien

1953

-
11.07 %
indirectly
KA

Kjell Arne Aaser

1952

-
6.55 %
indirectly
JJ

Jarle Jortveit

1974

-
5.82 %
indirectly
LP

Lars Peder Fosse Fensli

1976

Board Member
4.24 %
indirectly
TY

Tord Ytterdahl

1970

Managing Director/CEO
3.54 %
indirectly
HF

Helene F Hvalgård-Bakke

1981

-
2.77 %
indirectly
RW

Rune Werner Fensli

1950

-
2.77 %
indirectly
MF

Mari Fensli

1978

-
2.77 %
indirectly
AK

Axel Kogstad Bendvold

1990

Board Member
2.45 %
indirectly
Last update: May 15, 2024

Ownership

Company shareholders

NameShare classTotal number of sharesShare
U
UTHALDEN AS
Ordinary shares
21,801
20.11 %
A
AGDER SEED AS
Ordinary shares
12,867
11.87 %
B
BJØRN BREIEN AS
Ordinary shares
12,008
11.07 %
F
FENSLI CONSULTING AS
Ordinary shares
12,000
11.07 %
L
LUCELLUM AS
Ordinary shares
7,100
6.55 %
C
CORSULT AS
Ordinary shares
6,312
5.82 %
V
VERD INVESTERING AS
Ordinary shares
5,365
4.95 %
E
ERBE INVEST AS
Ordinary shares
4,450
4.1 %
G
GREMSDALEN INVEST AS
Ordinary shares
3,837
3.54 %
G
GUMPENS INVEST AS
Ordinary shares
3,308
3.05 %
M
MA-INVEST AS
Ordinary shares
1,838
1.7 %
F
FENSLI INVEST AS
Ordinary shares
1,600
1.48 %
C
CONTINA AS
Ordinary shares
1,500
1.38 %
S
SOLLYS INVEST AS
Ordinary shares
1,286
1.19 %
L
LEXA INVEST AS
Ordinary shares
1,039
0.96 %
A
AXCE HOLDING AS
Ordinary shares
1,039
0.96 %
MN

Morten Neset

1950

Ordinary shares
1,000
0.92 %
R
RESULTATFORUM AS
Ordinary shares
765
0.71 %
P
PAGIN HOLDING AS
Ordinary shares
704
0.65 %
JP

Jens Petter Rønning

1945

Ordinary shares
700
0.65 %
S
SIFRE AS
Ordinary shares
691
0.64 %
S
SEVEN PEAKS NORWAY AS
Ordinary shares
673
0.62 %
N
NORDEN CORPORATE FINANCE AS
Ordinary shares
625
0.58 %
D
DR.NO INVEST AS
Ordinary shares
607
0.56 %
N
NIVEST AS
Ordinary shares
580
0.53 %
C
CETIUM AS
Ordinary shares
500
0.46 %
H
HIGEN HOLDING AS
Ordinary shares
492
0.45 %
A
ASPHEIMEN AS
Ordinary shares
415
0.38 %
G
GS CONSULTING AS
Ordinary shares
415
0.38 %
B
BOBE INVEST AS
Ordinary shares
368
0.34 %
KT

Kjetil Todnem

1972

Ordinary shares
365
0.34 %
C
CONCORDIA VIKING AS
Ordinary shares
300
0.28 %
TR

Tor Reier Lilleholt

1972

Ordinary shares
290
0.27 %
T
TRIPPEL S AS
Ordinary shares
213
0.2 %
E
EK KONSULENTTJENESTER AS
Ordinary shares
210
0.19 %
S
STAFF INVEST AS
Ordinary shares
200
0.18 %
SL

Siri Lindland

1973

Ordinary shares
138
0.13 %
C
CILARIS AS
Ordinary shares
135
0.12 %
OJ

Ole Jacob Østberg

1948

Ordinary shares
122
0.11 %
F
FRIMAN AS
Ordinary shares
120
0.11 %
S
SMESTAD MEDISINSKE SENTER AS
Ordinary shares
116
0.11 %
S
SMESTADKLINIKKEN AS
Ordinary shares
116
0.11 %
KJ

Kjell Jarl Hjelle

1958

Ordinary shares
75
0.07 %
PL

Per Larsen

1960

Ordinary shares
61
0.06 %
MA

Marie Amalie Guttormsen

1951

Ordinary shares
60
0.06 %
J
JGB CORPORATE AS
Ordinary shares
20
0.02 %
Last update: Jun 2, 2025

Financials

in NOK

Summary

Year20252024202320222021
Total operating income
10,802,461
6,975,448
5,106,547
3,177,222
2,078,475
Annual Total Result
-10,321,527
-8,631,632
-12,901,769
-7,395,524
-8,460,628
Total assets
15,181,051
23,649,670
19,691,896
19,578,101
26,879,980
Total liabilities
7,686,629
5,833,720
5,420,122
4,204,462
4,110,817
Total equity
7,494,422
17,815,949
14,271,774
15,373,639
22,769,163

P&L

Year20252024202320222021
Total operating income
10,802,461
6,975,448
5,106,547
3,177,222
2,078,475
Total operating costs
21,179,941
15,817,591
17,855,943
10,468,708
10,569,019
Operating result
-10,377,480
-8,842,143
-12,749,396
-7,291,486
-8,490,544
Financial income/costs
55,953
210,510
-152,373
-104,038
29,916
Profit before tax
-10,321,527
-8,631,632
-12,901,769
-7,395,524
-8,460,628
Total tax & extraordinary income/cost
0
0
0
0
0
Annual Total Result
-10,321,527
-8,631,632
-12,901,769
-7,395,524
-8,460,628

Balance overview

Year20252024202320222021
Total fixed assets
6,201,400
10,467,100
10,092,800
12,495,000
8,628,255
Total current assets
8,979,651
13,182,570
9,599,096
7,083,101
18,251,725
Total assets
15,181,051
23,649,670
19,691,896
19,578,101
26,879,980
Short term debt
2,612,962
2,742,589
1,867,742
2,027,087
1,610,817
Long term debt
0
3,091,131
3,552,380
2,177,375
2,500,000
Total liabilities
7,686,629
5,833,720
5,420,122
4,204,462
4,110,817
Contributed capital
7,494,422
17,815,949
14,271,774
15,373,639
22,769,163
Retained earnings
0
0
0
0
0
Total equity
7,494,422
17,815,949
14,271,774
15,373,639
22,769,163
Total equity and liabilities
15,181,051
23,649,670
19,691,896
19,578,101
26,879,980

Classification

21st company classification
BETA
Scaleup
Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
C
Main industrial area
Manufacturing
21
Activity
Manufacture of basic pharmaceutical products and pharmaceutical preparations
21.2
Main industrial group
Manufacture of pharmaceutical preparations
21.20
Industrial group
Manufacture of pharmaceutical preparations
21.200
Industrial group
Manufacture of pharmaceutical preparations